FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 67 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q4 2018. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $180,000 | -37.3% | 50,000 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $287,000 | -48.3% | 50,000 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $555,000 | +19.9% | 50,000 | 0.0% | 0.00% | +100.0% |
| Q3 2016 | $463,000 | -4.9% | 50,000 | -16.7% | 0.00% | -50.0% |
| Q4 2015 | $487,000 | +10.7% | 60,000 | 0.0% | 0.00% | +100.0% |
| Q3 2015 | $440,000 | -28.5% | 60,000 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $615,000 | +10.8% | 60,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $555,000 | +58.1% | 60,000 | +20.0% | 0.00% | +100.0% |
| Q4 2014 | $351,000 | +28.6% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $273,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 4,781,708 | $28,738,000 | 4.90% |
| DSC Advisors, L.P. | 1,187,604 | $7,138,000 | 4.14% |
| Opaleye Management Inc. | 960,000 | $5,769,000 | 1.85% |
| DAFNA Capital Management LLC | 352,741 | $2,120,000 | 1.14% |
| Vivo Capital, LLC | 855,000 | $5,139,000 | 1.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 382,838 | $2,301,000 | 0.81% |
| SENZAR ASSET MANAGEMENT, LLC | 377,397 | $2,268,000 | 0.58% |
| Sio Capital Management, LLC | 131,200 | $789,000 | 0.44% |
| Perceptive Advisors | 1,117,324 | $6,715,000 | 0.22% |
| Tekla Capital Management LLC | 930,398 | $5,592,000 | 0.22% |